CN106456681A - Tablet containing sake yeast - Google Patents
Tablet containing sake yeast Download PDFInfo
- Publication number
- CN106456681A CN106456681A CN201580028888.2A CN201580028888A CN106456681A CN 106456681 A CN106456681 A CN 106456681A CN 201580028888 A CN201580028888 A CN 201580028888A CN 106456681 A CN106456681 A CN 106456681A
- Authority
- CN
- China
- Prior art keywords
- coating
- tablet
- saccharomyces sake
- mass
- glycerine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The purpose of the present invention is to obtain a coating agent that has excellent coating characteristics and is problem-free in terms of appearance, odor and flavor. The present invention provides a tablet containing sake yeast, said tablet being coated with a coating agent containing hydroxypropyl methylcellulose and glycerol. The ratio (A/B) of the coating percentage (A) of the hydroxypropyl methylcellulose to the coating percentage (B) of the glycerol is 2 to 20, and the content of sake yeast cells (C) is 15 mass% with respect to an uncoated tablet.
Description
Technical field
The present invention relates to the tablet containing saccharomyces sake.
Background technology
The nutrient contents such as abundant vitamins, amino acids, food fiber, mineralogical composition are contained in saccharomyces sake.Cause
This, can expect to reach nutritional supplementation, prevention disease and other effects by absorbing saccharomyces sake.
Tablet containing saccharomyces sake and saccharomyces sake in itself compared with, can more easily take.Therefore, containing saccharomyces sake
Tablet is as being useful for obtaining the nutritional supplementation effect that saccharomyces sake is played.But, mend to obtain above-mentioned nutrition
Fill or other effects, need to absorb the saccharomyces sake of more amount.Therefore, if the content of saccharomyces sake is few in tablet, absorb
Tablet can become excessive, taking goes wrong.Therefore, in order to improve the taking of the tablet containing saccharomyces sake,
Need to improve the yeast concentration in tablet.But, if improving the yeast concentration in tablet, produce the hardship from saccharomyces sake
Taste, the problem of distinctive smell.
As the technology suppressing such bitter taste, smell, there is technology tablet being coated by coating agent.Patent literary composition
Offer the tablet recorded in 1 with cellulose derivative is dried thalline to the microorganism containing SAM (SAMe) to enter
Row coating, and describe preparation example hydroxypropyl methyl cellulose being used as cellulose derivative.
Prior art literature
Patent document
Patent document 1:International Publication No. 2009/081833
Content of the invention
Invent problem to be solved
But, the method described in patent document 1, its object is to make contained stable components in yeast it is difficult to prevent
The only decortication of generation, wrinkling, the coating property variation such as sliver, sticking.
It is an object of the invention to, obtain a kind of excellent, the bag of equal no problem in terms of outward appearance, aroma and flavor of coating property
Clothing agent.
The technical scheme of solve problem
The present inventor has carried out deep discussion to solve above-mentioned problem.During find will be fine for hydroxypropyl methyl
Dimension element uses as coating agent with glycerine is combined, can keep good coating.Further, by adjusting hydroxypropyl methyl
The balance of cellulose and glycerine coating rate, can keep good outward appearance, aroma and flavor.
The present invention provides (1)~(3).
(1) a kind of tablet, it is the plain piece containing saccharomyces sake, and this plain piece is by the bag containing hydroxypropyl methyl cellulose and glycerine
Clothing agent coating forms, wherein,
The coating rate (A) of hydroxypropyl methyl cellulose is 2~20 with respect to the ratio (A/B) of the coating rate (B) of glycerine,
The content of saccharomyces sake thalline (C) is with respect to plain piece more than 15 mass %.
(2) tablet according to (1), wherein, the coating rate (B) of glycerine is 0.025%~2.5%.
(3) tablet according to (1) or (2), wherein, the coating rate (A) of hydroxypropyl methyl cellulose is more than 0.5%.
Invention effect
A kind of coating property can be provided excellent according to the present invention, in containing of the aspect no problem such as outward appearance, aroma and flavor
The coated tablet of saccharomyces sake.
Specific embodiment
Saccharomyces sake is contained in the tablet of the present invention.Saccharomyces sake is the yeast using when brewageing pure mellow wine.When brewageing pure mellow wine
The yeast using principally falls into saccharomyces cerevisiae (S.cerevisiae).As saccharomyces sake, No. 6 yeast (K- of association can be enumerated
6), No. 7 yeast (K-7) of association, No. 9 yeast (K-9) of association, No. 601 yeast (K-601) of association, No. 701 yeast (K- of association
701), No. 901 yeast (K-901) of association, No. 1001 yeast (K-1001) of association, No. 1501 yeast (K-1501) of association (are
Public good juridical person Japan brewages association and promulgates).Saccharomyces sake can be any one of raw thalline and dead thalline.
Saccharomyces sake is usually dried thalline.Part warp that thalline be the thalline such as the fragment of thalline and/or thalline is dried
The product of dried process gained.As dried process, freeze-drying, drying under reduced pressure can be enumerated, ventilating is dried, is spray-dried.
Thalline is dried and is usually powder.
With respect to the quality of plain piece of the present invention, the content of saccharomyces sake thalline (C) (dry mass) is as in every tablet
The content of saccharomyces sake, more than plain piece usually 15 mass %, more than preferably 20 mass %, more preferably 23 mass % with
On.Thus, it is possible to piece numerical control system will be absorbed in proper range, taking therefore can be improved.The upper limit preferably 70 mass % with
Under, below more preferably 60 mass %, below further preferred 50 mass %.Thus, it is possible to prevent from saccharomyces sake
Bitter taste, distinctive smell, can keep taste and smell.In every tablet, the content of saccharomyces sake thalline (C) is with respect to plain piece,
Preferably 15 mass %~70 mass %, more preferably 20 mass %~60 mass %, further preferred 23 mass %~50 mass %.
Saccharomyces sake thalline (C) in the tablet of the present invention is contained in saccharomyces sake.Saccharomyces sake and saccharomyces sake bacterium
Body (C) is sometimes identical.Additionally, the composition beyond saccharomyces sake thalline (C) can also be contained in saccharomyces sake.As this pure mellow wine ferment
Composition beyond female thalline (C), for example, can enumerate:Zymotic fluid, culture supernatant etc..
The tablet of the present invention, can be coated to the plain piece containing saccharomyces sake by coating agent.Coating agent contains hydroxyl
Propyl methocel and glycerine.
Hydroxypropyl methyl cellulose (another name:HPMC the viscosity in 20 DEG C of the 2 mass % aqueous solution), preferably 2mm2/ s with
On, more preferably 4mm2/ more than s.The preferred 10mm of the upper limit2/ below s, more preferably 8mm2/ below s.Thus, it is possible to realize film formability
Good coating.
The substitution value of hydroxypropyl methyl cellulose, methoxyl content preferably more than 15%, more preferably more than 20%.The upper limit is excellent
Select less than 40%, more preferably less than 30%.Additionally, hydroxypropoxy content preferably more than 2%, more preferably more than 5%.The upper limit is excellent
Select less than 15%, more preferably less than 12%.Thus, it is possible to realize the good coating of film formability.
As hydroxypropyl methyl cellulose, can enumerate:The METOLOSE60SH-03 of Shin-Etsu Chemial Co., Ltd,
60SH-06, SE-06, MCE-4, SB-4, SM-4, TC-5E, TC-5M, TC-5R etc..Wherein, particularly preferred SE-06, TC-5R.
The coating rate (A) of hydroxypropyl methyl cellulose, preferably more than 0.5%, more preferably more than 1%.The upper limit preferably 10%
Hereinafter, more preferably less than 5%, further preferred less than 3%.This coating rate preferably 0.5%~10%, more preferably 0.5%~
5%, further preferred 1%~3%.
If the coating rate (A) of hydroxypropyl methyl cellulose, more than preferred lower limit, can more reduce from pure mellow wine ferment
The bitter taste of mother, distinctive smell, if below preferred higher limit, can get the better tablet of disintegrative.
As glycerine, it is possible to use Japanese Pharmacopoeia or glycerine specified in food additives statutory document.
The coating rate (B) of glycerine, preferably more than 0.025%, more preferably more than 0.1%.The upper limit preferably less than 2.5%, more
Preferably less than 0.8%.This coating rate preferably 0.025%~2.5%, more preferably 0.1%~0.8%.
If the coating rate (B) of glycerine, more than preferred lower limit, can keep better coating, if preferred
Higher limit below, then be more difficult to over time through generation cosmetic variation.
Coating rate in the present invention is the numerical value being calculated by following formula.
(formula)
Coating rate=(quality of the content/plain piece of coating constituents) × 100
In tablet the coating rate (A) of hydroxypropyl methyl cellulose with respect to the ratio (A/B) of the coating rate (B) of glycerine 2
More than, preferably more than 4.The upper limit preferably less than 20, preferably less than 10.This ratio is 2~20, preferably 4~10.
If (A/B) more than preferred lower limit and below higher limit, better coating can be kept.
Coating agent can contain the composition in addition to ylmethyl cellulose and glycerine.As this composition, can enumerate poly-
Vinyl alcohol, polyvinylpyrrolidone etc. synthesize macromolecule;The polyalcohols such as polyethylene glycol, propane diols, glycerine;Triacetyl glycerine,
The synthesizing esters such as triethyl citrate, fatty acid glyceride;Carboxymethylcellulose calcium, hydroxypropyl cellulose, methylcellulose, ethyl
The cellulose families such as cellulose;The natural materials such as shellac, pulullan polysaccharide, gum arabic;Or these combination.Additionally, can
To be added as needed on the pigment such as titanium oxide, iron oxide;Any conditions such as mannitol, cetanol, NaLS.Additionally,
After film coating, Brazil wax as polishing material etc. can be added.
As long as the effect not giving the present invention does not bring bad influence, in the amount of the degree of the effect not damaging the present invention, can
With any condition used in the manufacture containing tablets such as other pharmaceuticals, the outer product of medicine, food.As any condition, for example
Can enumerate:Excipient, adhesive, disintegrant, enteric polymer, insoluble polymer, lubricant, surfactant,
Toner, flavor enhancement, adsorbent, antistatic additive, disintegration extend agent, foaming agent etc..
As excipient, for example, can enumerate:Starch, cornstarch, granulated sugar, mannitol, avicel cellulose, magnesium carbonate, carbon
Sour calcium, castor sugar, glucose, dextrose hydrate, lactose, silica (another name:Silicic acid anhydride, silica particle), low
Replace hydroxypropyl cellulose etc..The content of excipient is not particularly limited, preferably 0.1~80 mass % in terms of amounting to, further
Preferably 10~70 mass %.
As adhesive, for example, can enumerate:Sucrose, gelatin, gummi arabicum pulveratum, methylcellulose, hydroxypropyl cellulose, hydroxyl
Propyl methocel, carboxymethylcellulose calcium, calcium carboxymethylcellulose, polyvinylpyrrolidone, pulullan polysaccharide, dextrin, pre-
Gelatinized starch etc..The content of adhesive is not particularly limited, preferably 0.1~10 mass %, further preferred 1~5 mass %.
As disintegrant, for example, can enumerate:Cross-linked carboxymethyl sodium, insoluble PVPP, partial gelatinization
Starch, PVPP, calcium carboxymethylcellulose (another name:Carmellose Calcium, CMC-Ca), sodium carboxymethyl starch,
Cornstarch etc..The content of disintegrant is not particularly limited, preferably 0.1~30 mass %, further preferred 1~20 mass %.
As enteric polymer, for example, can enumerate:Hydroxypropyl methyl cellulose phthalic acid, acetate propionate fiber
Element, carboxymethylethylcellulose etc..
As insoluble polymer, for example, can enumerate:Eudragit E100 is (for example,
Eudragit E, Eudragit RS etc.), methacrylic acid copolymer (for example, Eudragit L30-55 etc.) etc..
As lubricant, for example, can enumerate:Polyethylene glycol, talcum, stearic acid or its salt (for example, calcium stearate), sucrose
Fatty acid ester etc..The content of lubricant is not particularly limited, preferably 0.001~5 mass %, further preferred 0.01~3 matter
Amount %.As this sucrose fatty ester, for example, can enumerate:Surfhope SE Cosme C 1216, Sucrose myristate, sucrose palmitate,
Sucrose stearate etc..As Surfhope SE Cosme C 1216, can enumerate:Sucrose monolaurate, sucrose dilaurate, sucrose March
Cinnamic acid ester etc.;As Sucrose myristate, can enumerate:Sucrose monomyristate, sucrose two myristinate, sucrose three meat
Myristate etc.;As sucrose palmitate, can enumerate:Sucrose palmitic acid ester, sucrose dipalmitate, sucrose three palmitic acid
Ester etc.;As sucrose stearate, can enumerate:Sucrose monostearate, sucrose distearate, sucrose tristearate etc..
As surfactant, for example, can enumerate:The anionic surfactant such as sodium alkyl sulfate, polyoxyethylene
Nonionic surface active agent such as Span, polyoxyethylene fatty acid ester and castor oil derivatives etc..
As colouring agent, for example, can enumerate:Tar pigment, caramel, kermes, titanium oxide, riboflavin class, green-tea extract,
Chlorophyll copper sodium, edible Sunset Yellow FCF, edible Amaranth, eat blue No. 2 and wait food coloring, edible color lake pigment etc..
As flavor enhancement, for example, can enumerate:Sweetener (for example, saccharin sodium, dipotassium glycyrrhizinate, Aspartame, stevioside,
Artificial sweetening agents such as Talin etc.), spices (for example, lemon, lemon bitter orange, orange, L- menthol, peppermint oil, peppermint MICRON
X-8277-T, Dry Coat smears tea #421 etc.), acid (for example, citric acid, tartaric acid, malic acid etc.), green tea powder etc..
As adsorbent, for example, can enumerate:Special calcium silicates (fluorite) etc..
Extend agent as antistatic additive, disintegration, for example, can enumerate:Light anhydrous silicic acid etc..
As foaming agent, for example, can enumerate:Sodium bicarbonate etc..
The manufacture method of the tablet of the present invention is not particularly limited, and is exemplified below one and illustrates.First, obtain element
Piece.Plain piece can be granulated using methods such as wet type granulation, dry type granulations as needed.Additionally, can obtain by the following method
Plain piece:Mix plain piece raw material and carry out the direct compression method of compressing tablet;After dry type particle is made in compressed shaping, or add water
Carry out after mixed solvent kneading/granulate/drying make wet granulate after and or by after making additive and being dissolved in water equal solvent
Carry out after spray drying makes wet granulate, making the indirect pressed disc method of compressed tablets;Or the method that these are combined.Connect
, mixing hydroxypropyl methyl cellulose, glycerine and desired any condition simultaneously prepare coating solution, by coating solution Direct spraying or
The Coating Solution adding water is sprayed in plain piece, defines coating membrane by being dried on plain piece surface, it is hereby achieved that
The tablet of the present invention.
[embodiment]
Below, with reference to embodiment, the present invention is described in more detail, but embodiments of the present invention are not limited to
These embodiments
Embodiment 1~14 and comparative example 1 and 2
(plain piece 1 and 2)
When manufacturing the saccharomyces sake tablet in each embodiment, make the plain piece 1 and 2 of coating object.The composition of plain piece such as table 1 institute
Show.
[table 1]
(footnote in table 1)
The amount (saccharomyces sake thalline (C) amount=saccharomyces sake amount × 0.7) of the saccharomyces sake thalline (C) in ※ saccharomyces sake is [dry
Drying quality]
The content unit of each composition:Mg/ piece
The manufacture method of plain piece is as follows.By saccharomyces sake (dry yeast containing SAMe, Mitsubishi's gas chemistry strain formula
Biomass 70% in commercial firm's system, yeast powder) and silica particle (Carplex FPS-500, DSL Amada Co., Ltd.
System) mixing after, add and mixed crystallization cellulose (CEOLUS (registration mark) UF-F711, Asahi Chemical Corp's system)
With calcium carboxymethylcellulose (E.C.G-FA, sun chemical industry Co. Ltd. system), then add and mix calcium stearate (stearic
Sour calcium, peaceful Chemical Industries Co. Ltd. system), compressing tablet is carried out under 12kgN by direct compression method.Compressing tablet uses rotary pressure
Piece machine (LIBRA2, Kikusui Seisakusho Ltd.'s system).
Coating agent in table 2~4 is dissolved in the water, is configured to the coating solution of concentration 5%.On the other hand, by 200Kg element
Piece loads in seed-coating machine (DRC-14000S, P Co., Ltd.'s owrex system), with 65 DEG C of feed air temperature, revolution 1rpm, the row of being preheated to
After temperature degree is 45 DEG C, spray coating liquid under conditions of revolution 5rpm/ spray liquid speed 300mL/min.After spraying terminates, do
Dry to delivery temperature be 50 DEG C, terminate coating.It is explained, the hydroxypropyl methyl cellulose (commodity used in each embodiment
Name:METOLOSE SE-06, manufacturer's name:Shin-Etsu Chemial Co., Ltd) have the following properties that:2 mass % when 20 DEG C
The viscosity of the aqueous solution is 5.9mm2/s;Methoxyl content is 28.9%;Hydroxypropoxy content is 9.0%.Additionally, glycerine uses
Food additives glycerine, it is by slope this pharmaceutical industries Co. Ltd. system.
The coating of each tablet obtaining, outward appearance, aroma and flavor are evaluated.Coating property be evaluated as:Range estimation is seen
Examine the decortication of coating, wrinkling, sliver situation in the tablet just having produced, and evaluated according to standard shown below.Piece
The ocular estimate of agent is the changing condition that visual observations save outside color in the tablet of 4 months in 40 DEG C of thermostats, and
Evaluated according to standard shown below.The evaluation of aroma and flavor is one group of 5 people smell/taste to the tablet just having produced
Road is evaluated, and is evaluated according to standard shown below.
[criterion of coating property]
Appreciable coating decortication, wrinkling, sliver tablet, if be less than 2 in 100 then it is assumed that can accept.
◎:It can be seen that decortication, wrinkling, sliver tablet, in 100, it is 0
○:It can be seen that decortication, wrinkling, sliver tablet, in 100, it is more than 1 and less than 2
Δ:It can be seen that decortication, wrinkling, sliver tablet, in 100, it is more than 3 and less than 5
×:It can be seen that decortication, wrinkling, sliver tablet, in 100, it is more than 6
[criterion of outward appearance]
The preservation product of 4 months and the preservation condition ratio of shady place (5 DEG C) is saved, if appearance color is almost without change at 40 DEG C
Change then it is assumed that can accept.
◎:Appearance color is unchanged
○:Appearance color is almost unchanged
Δ:It can be seen that appearance color change is less
×:It can be seen that appearance color change is more
[criterion of aroma and flavor]
The average mark of one group of 5 people is if above 4 points then it is assumed that can accept.
5 points:Do not feel smell/taste
4 points:Feel smell/taste slightly
3 points:Feel smell/taste
2 points:Feel apparent smell/taste
1 point:Feel very big smell/taste
<Evaluate>
◎:Average mark is higher than 4.5 points
○:Average mark is higher than 4 points and less than 4.5 points
△:Average mark is higher than 3 points and less than 4 points
×:Average mark is less than 3 points
In each embodiment and comparative example, the species of plain piece, coating conditions and evaluation result are as shown in table 2~4.
[table 2]
[table 3]
[table 4]
As clearly shown in table 2~4, the tablet of embodiment 1~14 is all evaluated as well in coating property and outward appearance, smell and taste
Road is also within the acceptable range.On the other hand, A/B be less than 2 comparative example 1 coating agent coating property, outward appearance, smell and
Taste is all poor, and, in coating agent, coating property, aroma and flavor are all poor for the comparative example 2 more than 20 for the A/B.This result shows this
The coating of bright tablet is excellent, outward appearance aspect also no problem, in terms of smell, taste also without a doubt.
(Formulation Example)
<Tablet>
In addition to the combined amount of each composition, tablet is obtained by method similarly to Example 1.The composition of tablet such as table 5 institute
Show.
[table 5]
(A):Coating rate (%)/(B) of (a):Coating rate (the %)=1.333/0.167=8 of (b).
Claims (3)
1. a kind of tablet, it is the plain piece containing saccharomyces sake, and this plain piece is by the bag containing hydroxypropyl methyl cellulose and glycerine
Clothing agent coating forms,
Wherein, the coating rate (A) of hydroxypropyl methyl cellulose is 2~20 with respect to the ratio A/B of the coating rate (B) of glycerine,
The content of saccharomyces sake thalline (C) is more than 15 mass % with respect to plain piece.
2. tablet according to claim 1, wherein, the coating rate (B) of glycerine is 0.025%~2.5%.
3. tablet according to claim 1 and 2, wherein, the coating rate (A) of hydroxypropyl methyl cellulose is more than 0.5%.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014-119949 | 2014-06-10 | ||
JP2014119949 | 2014-06-10 | ||
PCT/JP2015/066559 WO2015190456A1 (en) | 2014-06-10 | 2015-06-09 | Tablet containing sake yeast |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106456681A true CN106456681A (en) | 2017-02-22 |
CN106456681B CN106456681B (en) | 2019-11-22 |
Family
ID=54833546
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201580028888.2A Active CN106456681B (en) | 2014-06-10 | 2015-06-09 | Tablet containing saccharomyces sake |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP6456377B2 (en) |
KR (1) | KR20170015315A (en) |
CN (1) | CN106456681B (en) |
WO (1) | WO2015190456A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106119009A (en) * | 2016-08-31 | 2016-11-16 | 广东省九江酒厂有限公司 | A kind of fruital pure rice wine and brewing method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003506481A (en) * | 1999-08-12 | 2003-02-18 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Oral dosage form |
JP2007031407A (en) * | 2005-07-29 | 2007-02-08 | Shin Etsu Chem Co Ltd | Coating composition containing cellulose ether with low substitution degree, and film-coated preparation with concealed unpleasant taste |
WO2009081833A1 (en) * | 2007-12-20 | 2009-07-02 | Kaneka Corporation | Dried microorganism cell or microorganism extract containing stabilized (ss)-s-adenosyl-l-methionine, and method for production of the dried microorganism cell or microorganism extract |
JP2010037326A (en) * | 2008-07-10 | 2010-02-18 | Taisho Pharmaceutical Co Ltd | Drug particle for carrying medicine having unpleasant taste |
CN101795676A (en) * | 2007-09-01 | 2010-08-04 | Lts罗曼治疗方法有限公司 | Comprise zymic drug products |
CN103458709A (en) * | 2011-01-21 | 2013-12-18 | 凡赛尔医药股份有限公司 | Microencapsulated probiotic substance and process of manufacture |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL72381A (en) * | 1983-07-20 | 1988-03-31 | Sanofi Sa | Pharmaceutical composition based on valproic acid |
ZA881301B (en) * | 1987-02-27 | 1989-10-25 | Lilly Co Eli | Sustained release matrix formulations |
-
2015
- 2015-06-09 JP JP2016527805A patent/JP6456377B2/en active Active
- 2015-06-09 WO PCT/JP2015/066559 patent/WO2015190456A1/en active Application Filing
- 2015-06-09 CN CN201580028888.2A patent/CN106456681B/en active Active
- 2015-06-09 KR KR1020167034060A patent/KR20170015315A/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003506481A (en) * | 1999-08-12 | 2003-02-18 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Oral dosage form |
JP2007031407A (en) * | 2005-07-29 | 2007-02-08 | Shin Etsu Chem Co Ltd | Coating composition containing cellulose ether with low substitution degree, and film-coated preparation with concealed unpleasant taste |
CN101795676A (en) * | 2007-09-01 | 2010-08-04 | Lts罗曼治疗方法有限公司 | Comprise zymic drug products |
WO2009081833A1 (en) * | 2007-12-20 | 2009-07-02 | Kaneka Corporation | Dried microorganism cell or microorganism extract containing stabilized (ss)-s-adenosyl-l-methionine, and method for production of the dried microorganism cell or microorganism extract |
JP2010037326A (en) * | 2008-07-10 | 2010-02-18 | Taisho Pharmaceutical Co Ltd | Drug particle for carrying medicine having unpleasant taste |
CN103458709A (en) * | 2011-01-21 | 2013-12-18 | 凡赛尔医药股份有限公司 | Microencapsulated probiotic substance and process of manufacture |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106119009A (en) * | 2016-08-31 | 2016-11-16 | 广东省九江酒厂有限公司 | A kind of fruital pure rice wine and brewing method thereof |
CN106119009B (en) * | 2016-08-31 | 2019-11-08 | 广东省九江酒厂有限公司 | A kind of fruity pure rice wine and its brewing method |
Also Published As
Publication number | Publication date |
---|---|
CN106456681B (en) | 2019-11-22 |
KR20170015315A (en) | 2017-02-08 |
JPWO2015190456A1 (en) | 2017-04-20 |
WO2015190456A1 (en) | 2015-12-17 |
JP6456377B2 (en) | 2019-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4890260B2 (en) | Film-forming starch composition | |
CN102791271B (en) | Method for improving dissolvability of anticoagulant | |
TW201625309A (en) | Disintegrating particle composition including microfibrous cellulose | |
JP6940600B2 (en) | Composition for disintegrating tablets containing microfibrous cellulose and active ingredient | |
JP2016174616A (en) | Disintegrable composition, and easily disintegrable compression molding | |
CN101239044A (en) | Solid composition | |
CN106456681B (en) | Tablet containing saccharomyces sake | |
JP6800596B2 (en) | tablet | |
JP2008127350A (en) | Deodorizing solid composition | |
CN104490790B (en) | Cefuroxime axetil solid dispersion coated composition and preparation method thereof | |
JP2001039863A (en) | Production of soft capsule and coating agent or lubricant | |
CN106456682B (en) | Tablet containing sake yeast | |
JP7486258B2 (en) | Granules for orally disintegrating tablets, their manufacturing method and orally disintegrating tablets | |
JP7545204B2 (en) | tablet | |
JP2018108116A (en) | Method for producing royal jelly stock, royal jelly stock, royal jelly-containing food and drink, and royal jelly-containing cosmetic | |
JP2001103918A (en) | Method for improving gustatoriness and gustatoriness- improved persimmon juice preparation | |
TWI392505B (en) | Solid composition | |
JP2001199886A (en) | Taste-improving method and proanthocyanidin preparation for improving taste | |
CN106413728A (en) | Tablet containing sake yeast | |
WO2015190453A1 (en) | Sake-yeast-containing tablet | |
KR20240012091A (en) | Tablet film coating composition comprising partially hydrolyzed guar gum as a film coating base materials | |
CN101637443A (en) | Solid preparation containing cysteine with reduced smell | |
JP2008148647A (en) | Milk constituent-containing composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |